Odonate Therapeutics, Inc. (ODT): Price and Financial Metrics
ODT Price/Volume Stats
| Current price | $1.12 | 52-week high | $7.10 |
| Prev. close | $1.17 | 52-week low | $0.85 |
| Day low | $1.11 | Volume | 716,400 |
| Day high | $1.20 | Avg. volume | 1,223,190 |
| 50-day MA | $1.82 | Dividend yield | N/A |
| 200-day MA | $2.95 | Market Cap | 43.11M |
ODT Stock Price Chart Interactive Chart >
Odonate Therapeutics, Inc. (ODT) Company Bio
Odonate Therapeutics, LLC develops therapeutics to enhance the lives of patients with cancer in the United States. It is developing Tesetaxel, a novel chemotherapy agent that has completed Phase II clinical trials for patients with advanced or metastatic breast cancer. The company was founded in 2013 and is based in San Diego, California.
ODT Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -27.74% |
| 5-year | -85.18% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -71.88% |
| 2020 | -40.83% |
| 2019 | 130.47% |
Loading social stream, please wait...